Global Blockchain In Pharmaceutical Market Strategic Research Report

Scope of the Report

The global Blockchain In Pharmaceutical market size is predicted to grow from US$ 7,179 million in 2025 to US$ 141,540 million in 2032; it is expected to grow at a CAGR of 53.7% from 2026 to 2032.

Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.

Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.

Market Drivers

1. Supply Chain Transparency and Traceability

Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.

2. Counterfeit Drug Prevention

Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.

3. Regulatory Compliance

Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.

4. Improved Drug Recall Management

In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.

5. Enhanced Data Security and Privacy

Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.

This report presents a comprehensive overview of the global Blockchain In Pharmaceutical market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Private Blockchain
• Hybrid Blockchain

Segment by players, this report covers

• IBM
• AWS
• Microsoft
• SAP
• Chronicled
• Embleema
• FarmaTrust
• Guardtime Federal

Segment by Application

• Supply Chain Logistics
• Drug Safety
• Clinical Trial Management
• IOMT & Cyber Security

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Blockchain In Pharmaceutical market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Supply Chain Logistics, Drug Safety, Clinical Trial Management evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact